Genetically Modified IP Launched
A paper appearing in this week’s edition of Nature is antiseptically entitled: ‘Gene transfer to plants by diverse species of bacteria.’ But the information that lies within may herald a revolution in biology.
From the laboratory to the investment fund
How two Chilean scientists turned a graduate thesis into a business that is helping salmon and ham producers
Biotech: A Big Future Behind It?
Despite a bumpy 2004, the rush to market hasn’t abated. The key for this crop of newcomers: Holding investors’ attention?
The State of Stem Cell Research
Californians are hoping that stem cell research will do for them what the invention of the car did for Michigan
The Human Genome, Take Two
When a sequenced human genome was announced in 2001, most people missed a crucial part of the news: the genome was a first draft, sketchy and incomplete. This fall, scientists completed a new draft. The more complete version reveals that humans have a few thousand fewer genes than was previously predicted. [...]
Big Pharma’s Ails Could Spread To Biotech
It is no secret big drugmakers are sick. Investors should worry that their germs could spread to smaller, hotter biotech stocks.